Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

New class of antibiotics; dolphin ability to 'switch off' diabetes and why denture glue may be bad for you

Our roundup of news headlines on Friday 19 February.

Our roundup of news headlines on Friday 19 February.

The Times covers a new class of antibiotics developed by British scientists that could help to overcome the growing problem of drug-resistant infections.

A study in the journal Science, looks at the innovative compound, POL7080, which could enter clinical trials in the UK this year. According to the newspaper, the new compound could be effective against infections such as E. coli and helico bacteria.

A startling story that dolphins are able to turn diabetes on and off depending on whether they are hungry or not appears in the Telegraph.

In a finding that could lead to powerful treatments for diabetes in humans, the researchers found that the mammal can induce the condition when there is little food around and turn it off when food is abundant.

Britains youngest prostate cancer sufferer has made a full recovery. Ruddi Waterworth-Jones was just seven months old when he was diagnosed with the condition, but has been given the all-clear after pioneering treatment tin the USA.

The Daily Telegraph reports that the brain ‘actively erases memories to create space for new information'. The memories are erased by a protein in the body known as Rac – the little blighter apparently responsible for many an embarrassing situation when you have forgotten someone's name.

The top health news in the Daily Mail is a bit of a scare for those with false nashers. The manufacturers of popular denture adhesive Polygrip have been forced to remove zinc from its product after reports of neurological problems in long-term users, such as numbness or loss of balance.

The newspaper reports that GlaxoSmithKline advised customers who have used more adhesive than directed on the packaging over a number of years should stop using the products and seek medical advice.

Spotted a story we've missed? Let us know and we'll update the digest throughout the day...

Daily Digest - 19 February 2010

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say